Mammalian PGC development in vivo and in vitro, have been studied primarily using the mouse model as a template to study PGCs specification in other mammals including humans, porcine and bovine.The growing body of published works reveal similarities as well as differences in PGCs establishment in and between mouse and human

High dose intravenous immunoglobulin (HIVIg) therapy (20 g/day, 5 days) was performed in eight pregnancies from five women with antiphospholipid syndrome (APS) who had a history of pregnancy failure despite receiving low dose aspirin plus unfractionated heparin therapy. Five of the eight pregnancies ended in live birth. HIVIg therapy might be beneficial as an immune modifier for pregnant women with APS.

Decreased CBR1 expression promotes tumor growth via epithelial mesenchymal transition in uterine cervical squamous cell carcinomas.

Poor embryo quality was not associated with increased risk of adverse obstetric and neonatal outcomes.

Variations of the PD1 gene were confirmed to be risk factors for RPL. However, no predictive effect of the PD1 risk allele on subsequent pregnancy outcome have been identified.

A newly launched recombinant-hCG is useful as self-injection production for maturation trigger in ART treatment.

For non-mosaic Klinefelter syndrome with azoospermia, Micro-TESE is an effective sperm collection method.

In addition, in this study, we experienced a case with partial deletion of Azoospermia factor b in a nonmosaic Kleinfelter syndrome.

Even in Klinefelter's syndrome it is important to search for the Azoospermia factor microdeletion for prediction of sperm acquisition.